IGMS IGM Biosciences, Inc. Stock Quote

IGMS [NASD]

Index	-	P/E	-	EPS (ttm)	-2.64	Insider Own	42.70%	Shs Outstand	31.30M	Perf Week	-5.49%
Market Cap	1.96B	Forward P/E	-	EPS next Y	-5.93	Insider Trans	2.60%	Shs Float	14.44M	Perf Month	-29.40%
Income	-81.40M	PEG	-	EPS next Q	-0.98	Inst Own	68.70%	Short Float	24.69%	Perf Quarter	-39.59%
Sales	-	P/S	-	EPS this Y	-87.00%	Inst Trans	13.12%	Short Ratio	17.91	Perf Half Y	-26.03%
Book/sh	12.20	P/B	4.81	EPS next Y	-20.00%	ROA	-29.80%	Target Price	101.63	Perf Year	-2.17%
Cash/sh	10.95	P/C	5.36	EPS next 5Y	-	ROE	-32.50%	52W Range	41.41 - 133.00	Perf YTD	-33.53%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-55.87%	Beta	-
Dividend %	-	Quick Ratio	21.70	Sales past 5Y	-	Gross Margin	-	52W Low	41.73%	ATR	6.79
Employees	107	Current Ratio	21.70	Sales Q/Q	-	Oper. Margin	-	RSI (14)	31.31	Volatility	6.41% 9.91%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	4.00%	Profit Margin	-	Rel Volume	0.70	Prev Close	59.69
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Mar 30 AMC	Payout	-	Avg Volume	199.07K	Price	58.69
Recom	1.60	SMA20	-23.20%	SMA50	-31.95%	SMA200	-19.73%	Volume	139,563	Change	-1.68%

Jan-29-21

Initiated

RBC Capital Mkts

Outperform

$121

Jan-19-21

Reiterated

H.C. Wainwright

Buy

$88 → $114

Dec-22-20

Downgrade

Wedbush

Outperform → Neutral

Jul-17-20

Initiated

Robert W. Baird

Outperform

$90

Jul-01-20

Initiated

H.C. Wainwright

Buy

$88

May-28-20

Initiated

SunTrust

Buy

$86

Apr-22-20

Initiated

Wedbush

Outperform

$73

Oct-14-19

Initiated

Stifel

Buy

$32

Oct-14-19

Initiated

Piper Jaffray

Overweight

$26

Oct-14-19

Initiated

Jefferies

Buy

$25

Oct-14-19

Initiated

Guggenheim

Buy

$30

Apr-12-21 07:00AM	IGM Biosciences Appoints George Gauthier as Chief Commercial Officer GlobeNewswire -9.33%
Mar-30-21 04:17PM	IGM Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM	IGM Biosciences Inc to Host Earnings Call ACCESSWIRE
Mar-24-21 07:00AM	IGM Biosciences to Announce Fourth Quarter and Year-end 2020 Financial Results and Host Conference Call and Webcast on March 30, 2021 GlobeNewswire -11.57%
Mar-15-21 07:00AM	IGM Biosciences Appoints Lisa Decker, Ph.D., as Chief Business Officer GlobeNewswire
Mar-14-21 05:52AM	IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans Simply Wall St.
Mar-08-21 09:51AM	5 Value Stocks In The Healthcare Sector Benzinga -8.57%
Feb-05-21 07:00AM	IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day GlobeNewswire +5.14%
Jan-12-21 08:15AM	The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue Benzinga +6.80%
Jan-11-21 06:00PM	IGM Biosciences Enters into Exclusive Licensing Agreement with Medivir for Birinapant GlobeNewswire
Jan-07-21 07:00AM	IGM Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-23-20 10:32AM	Here Are the 2 Best Biotech Stocks in This Multibillion-Dollar Industry Motley Fool
Dec-21-20 10:45AM	This Biotech Skyrocketed 84% in 2 Days, But Is It Warranted? Motley Fool
Dec-17-20 01:43PM	Is IGMS A Good Stock To Buy Now? Insider Monkey
Dec-14-20 01:52AM	Have Insiders Been Buying IGM Biosciences, Inc. (NASDAQ:IGMS) Shares? Simply Wall St.
Dec-11-20 04:05PM	IGM Announces Closing of $230 Million Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire -8.76%
Dec-08-20 10:30PM	IGM Announces Pricing of Upsized $200 million Public Offering GlobeNewswire +57.75%
Dec-07-20 05:07PM	IGM Announces Proposed Public Offering GlobeNewswire +16.56%
Dec-05-20 01:30PM	IGM Biosciences Presents First Clinical Data from IGM-2323 in Non-Hodgkins Lymphoma at 2020 ASH Annual Meeting GlobeNewswire
Nov-30-20 07:00AM	IGM Biosciences to Host Conference Call and Webcast to Review IGM-2323 Data Presented at the 62nd Annual ASH Meeting GlobeNewswire
Nov-23-20 07:00AM	IGM Biosciences to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire
Nov-16-20 09:48AM	A Look Into Healthcare Sector Value Stocks Benzinga
Nov-09-20 07:00AM	IGM Biosciences to Present at Three Upcoming Investor Conferences GlobeNewswire +14.22%
Nov-05-20 07:02AM	IGM Biosciences Announces Third Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
Nov-04-20 09:20AM	IGM Biosciences to Present First Clinical Data from IGM-2323 in Non-Hodgkins Lymphoma at 2020 ASH Annual Meeting GlobeNewswire -6.67%
Sep-30-20 07:00AM	IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-8444 for the Treatment of Solid Cancers and Non-Hodgkins Lymphoma GlobeNewswire
Sep-24-20 04:01PM	AbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery Collaboration GlobeNewswire -5.41%
Sep-18-20 06:51PM	Scientific Games and Cracker Barrel See Activist Action Barrons.com +17.91%
Sep-16-20 09:00AM	IGM Biosciences (IGMS) Catches Eye: Stock Jumps 8.7% Zacks
Sep-14-20 12:04PM	Here's Why We're Not Too Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation Simply Wall St. +11.12%
Sep-02-20 07:00AM	IGM Biosciences to Present at Four Upcoming Investor Conferences GlobeNewswire +6.57%
Aug-06-20 04:08PM	IGM Biosciences Announces Second Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire -5.03%
Aug-04-20 07:00AM	IGM Biosciences to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference GlobeNewswire
Jun-28-20 05:58PM	Hedge Funds Getting Bullish On IGM Biosciences, Inc. (IGMS) Insider Monkey
Jun-16-20 06:27AM	IGM Biosciences, Inc. (NASDAQ:IGMS) Insiders Increased Their Holdings Simply Wall St.
May-28-20 07:00AM	IGM Biosciences to Present at the Jefferies 2020 Healthcare Conference GlobeNewswire
May-12-20 07:00AM	IGM Biosciences to Present at the 2020 RBC Capital Markets Global Healthcare Conference GlobeNewswire -8.33%
May-07-20 04:03PM	IGM Biosciences Announces First Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire +5.54%
12:25PM	Was The Smart Money Right About IGM Biosciences, Inc. (IGMS)? Insider Monkey
Apr-29-20 04:05PM	Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on Novel Antibody Treatment for COVID-19 GlobeNewswire
Apr-03-20 07:00AM	IGM Biosciences to Participate in Canaccord Genuity Horizons in Oncology Virtual Event GlobeNewswire
Mar-26-20 04:05PM	IGM Biosciences Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update GlobeNewswire -9.11%
02:30PM	IGM Biosciences Inc to Host Earnings Call ACCESSWIRE
Mar-19-20 07:00AM	IGM Biosciences to Announce Fourth Quarter and Year-end 2019 Financial Results and Host Conference Call and Webcast on March 26, 2020 GlobeNewswire +26.59%
Mar-04-20 07:00AM	IGM Biosciences to Present at Two Upcoming Investor Conferences GlobeNewswire +16.14%
Feb-06-20 07:00AM	IGM Biosciences to Present at Two Upcoming Investor Conferences GlobeNewswire
Jan-07-20 07:00AM	IGM Biosciences Appoints Eric Humke, M.D., Ph.D., as Vice President, Clinical Development, Apoptosis GlobeNewswire
Dec-22-19 01:29PM	Hedge Funds Have Never Been This Bullish On IGM Biosciences, Inc. (IGMS) Insider Monkey
Nov-12-19 07:00AM	IGM Biosciences to Present at Three Upcoming Investor Conferences GlobeNewswire
Nov-07-19 05:04PM	IGM Biosciences Announces Third Quarter 2019 Financial Results GlobeNewswire
Nov-01-19 10:24AM	3 Strong Buy Stocks Jefferies Thinks Are Set to Rip Higher TipRanks
Oct-02-19 07:00AM	IGM Biosciences Initiates First-in-Human Phase 1 Clinical Trial of IGM-2323 for the Treatment of Relapsed/Refractory B Cell Non-Hodgkins Lymphoma GlobeNewswire
Sep-20-19 04:05PM	IGM Biosciences Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Sep-18-19 11:03AM	IGM Biosciences Opens Above IPO Price Benzinga
07:39AM	The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts Benzinga
Sep-17-19 08:46PM	IGM Biosciences Announces Pricing of Initial Public Offering GlobeNewswire
04:04PM	IGM Biosciences IPO: What You Need To Know Benzinga

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of multiple diseases. Its lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 1 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). The company is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers and NHL; and IGM-7354, is a bispecific IgM antibody delivering interleukin-15 cytokines to PD-L1 expressing cells for use in the treatment of patients with solid and hematologic malignancies. It has a strategic research and license agreement with AbCellera to discover and develop IgM antibodies; and license agreement with AvantGen Inc. for various antibodies against the SARS-CoV-2 virus. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Keyt Bruce	Chief Scientific Officer	Apr 06	Sale	82.00	1,254	102,828	2,769	Apr 07 09:24 PM
Chen Daniel ShinYu	Chief Medical Officer	Apr 06	Sale	82.00	1,222	100,204	116,518	Apr 07 09:23 PM
Chen Daniel ShinYu	Chief Medical Officer	Apr 05	Option Exercise	1.39	1,900	2,641	118,418	Apr 07 09:23 PM
Keyt Bruce	Chief Scientific Officer	Apr 05	Option Exercise	0.93	2,500	2,325	5,269	Apr 07 09:24 PM
Tahir Misbah	Chief Financial Officer	Mar 05	Option Exercise	1.39	2,750	3,822	5,542	Mar 09 07:18 PM
Chen Daniel ShinYu	Chief Medical Officer	Mar 02	Sale	90.25	1,224	110,466	116,518	Mar 03 09:42 PM
Keyt Bruce	Chief Scientific Officer	Mar 02	Sale	90.25	1,619	146,115	2,769	Mar 03 09:43 PM
Keyt Bruce	Chief Scientific Officer	Mar 01	Option Exercise	0.93	2,500	2,325	5,269	Mar 03 09:43 PM
Chen Daniel ShinYu	Chief Medical Officer	Mar 01	Option Exercise	1.39	1,900	2,641	118,418	Mar 03 09:42 PM
Keyt Bruce	Chief Scientific Officer	Feb 03	Sale	96.00	1,619	155,424	2,769	Feb 04 08:12 PM
Chen Daniel ShinYu	Chief Medical Officer	Feb 03	Sale	96.00	1,226	117,696	116,473	Feb 04 08:11 PM
Chen Daniel ShinYu	Chief Medical Officer	Feb 02	Option Exercise	1.39	1,900	2,641	118,373	Feb 04 08:11 PM
Keyt Bruce	Chief Scientific Officer	Feb 02	Option Exercise	0.93	2,500	2,325	5,269	Feb 04 08:12 PM
BAKER BROS. ADVISORS LP	Director	Jan 27	Option Exercise	28.63	22,420	641,854	2,895,306	Jan 29 07:03 PM
Keyt Bruce	Chief Scientific Officer	Jan 05	Sale	79.33	1,503	119,233	2,769	Jan 06 08:39 PM
Chen Daniel ShinYu	Chief Medical Officer	Jan 05	Sale	79.25	1,102	87,334	116,473	Jan 06 08:37 PM
Chen Daniel ShinYu	Chief Medical Officer	Jan 04	Option Exercise	1.39	1,900	2,641	118,373	Jan 06 08:37 PM
Keyt Bruce	Chief Scientific Officer	Jan 04	Option Exercise	0.93	2,500	2,325	5,269	Jan 06 08:39 PM
Keyt Bruce	Chief Scientific Officer	Jan 04	Sale	88.07	883	77,766	1,013	Jan 06 08:39 PM
Tahir Misbah	Chief Financial Officer	Dec 21	Option Exercise	1.39	2,750	3,822	2,792	Dec 22 04:43 PM
Keyt Bruce	Chief Scientific Officer	Dec 17	Sale	86.10	1,618	139,310	2,769	Dec 18 07:47 PM
Keyt Bruce	Chief Scientific Officer	Dec 16	Option Exercise	0.93	2,500	2,325	5,269	Dec 18 07:47 PM
Topsoe Jakob Haldor	Director	Dec 11	Buy	90.00	111,111	9,999,990	10,400,564	Dec 15 08:31 PM
Topsoe Christina Teng	Director	Dec 11	Buy	90.00	111,111	9,999,990	10,400,564	Dec 15 08:30 PM
Haldor Topsoe Holding A/S	10% Owner	Dec 11	Buy	90.00	111,111	9,999,990	10,400,564	Dec 15 08:29 PM
BEHRENS M KATHLEEN	Director	Dec 11	Buy	90.00	44,444	3,999,960	22,222	Dec 15 08:28 PM
Chen Daniel ShinYu	Chief Medical Officer	Dec 08	Sale	91.00	1,219	110,929	116,473	Dec 09 07:43 PM
Chen Daniel ShinYu	Chief Medical Officer	Dec 07	Option Exercise	1.39	1,900	2,641	118,373	Dec 09 07:43 PM
Chen Daniel ShinYu	Chief Medical Officer	Dec 02	Sale	63.15	608	38,398	116,473	Dec 03 09:10 PM
Chen Daniel ShinYu	Chief Medical Officer	Dec 01	Option Exercise	1.39	950	1,320	117,423	Dec 03 09:10 PM
Chen Daniel ShinYu	Chief Medical Officer	Nov 04	Sale	50.00	605	30,250	116,473	Nov 04 08:28 PM
Chen Daniel ShinYu	Chief Medical Officer	Nov 02	Option Exercise	1.39	950	1,320	117,468	Nov 04 08:28 PM
Chen Daniel ShinYu	Chief Medical Officer	Oct 02	Sale	73.50	1,830	134,505	116,518	Oct 05 05:49 PM
Chen Daniel ShinYu	Chief Medical Officer	Oct 01	Option Exercise	1.39	2,850	3,961	119,368	Oct 05 05:49 PM
Keyt Bruce	Chief Scientific Officer	Oct 01	Sale	73.59	1,000	73,590	1,896	Oct 05 05:50 PM
Chen Daniel ShinYu	Chief Medical Officer	Sep 18	Sale	77.91	609	47,447	116,518	Sep 18 07:14 PM
Chen Daniel ShinYu	Chief Medical Officer	Sep 17	Option Exercise	1.39	950	1,320	117,468	Sep 18 07:14 PM
BEHRENS M KATHLEEN	Director	Sep 10	Buy	60.78	30,000	1,823,408	93,214	Sep 14 08:43 PM
Keyt Bruce	Chief Scientific Officer	Sep 10	Sale	60.00	1,000	60,000	2,896	Sep 14 08:43 PM
Redmile Group, LLC	Director	Sep 09	Buy	52.55	23,260	1,222,335	3,425,811	Sep 09 07:41 PM
Redmile Group, LLC	Director	Sep 08	Buy	49.91	47,113	2,351,504	3,402,551	Sep 09 07:41 PM
Chen Daniel ShinYu	Chief Medical Officer	Sep 08	Sale	50.20	602	30,220	116,518	Sep 09 07:17 PM
Redmile Group, LLC	Director	Sep 04	Buy	50.28	74,433	3,742,186	3,355,438	Sep 09 07:41 PM
Redmile Group, LLC	Director	Sep 03	Buy	48.69	74,253	3,615,208	3,281,005	Sep 03 07:57 PM
Redmile Group, LLC	Director	Sep 02	Buy	46.68	20,637	963,267	3,206,752	Sep 03 07:57 PM
Chen Daniel ShinYu	Chief Medical Officer	Sep 01	Option Exercise	1.39	950	1,320	117,468	Sep 03 05:52 PM
Redmile Group, LLC	Director	Sep 01	Buy	44.84	41,759	1,872,327	3,186,115	Sep 03 07:57 PM
Chen Daniel ShinYu	Chief Medical Officer	Aug 27	Sale	45.13	605	27,301	116,518	Aug 28 06:32 PM
Chen Daniel ShinYu	Chief Medical Officer	Aug 11	Option Exercise	1.39	950	1,320	117,468	Aug 13 04:35 PM
Keyt Bruce	Chief Scientific Officer	Jun 04	Option Exercise	3.34	2,987	9,984	4,000	Jun 08 06:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience